These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunotherapy (desensitization) in allergic disease. Norman PS Annu Rev Med; 1975; 26():337-44. PubMed ID: 1096771 [No Abstract] [Full Text] [Related]
5. [Desensitization by the extemporaneous combination of aluminum hydroxide with allergens (delayed-action allergens)]. Wolfromm R; Vallery-Radot C; Guibert L; Zalman Z Acta Allergol; 1969 Sep; 24(3):202-15. PubMed ID: 5395957 [No Abstract] [Full Text] [Related]
6. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. Gleich GJ; Zimmermann EM; Henderson LL; Yunginger JW J Allergy Clin Immunol; 1982 Oct; 70(4):261-71. PubMed ID: 6811645 [No Abstract] [Full Text] [Related]
7. Characteristics of human IgE antibody responses in vivo. Adkinson NF; Creticos PS; Norman PS; Mardiney MR; Rosenberg GL; Hamilton RG; Van Metre TE Monogr Allergy; 1983; 18():69-74. PubMed ID: 6646139 [No Abstract] [Full Text] [Related]
8. An overview of immunotherapy: implications for the future. Norman PS J Allergy Clin Immunol; 1980 Feb; 65(2):87-96. PubMed ID: 6153189 [No Abstract] [Full Text] [Related]
9. Study on specific immunotherapy with the aid of 3M Diagnostic Systems' tests. Stasiak-Barmuta A; Dabrowska I; Piotrowska T; Hofman J Pneumonol Alergol Pol; 1992; 60 Suppl 1():53-6. PubMed ID: 1292848 [No Abstract] [Full Text] [Related]
10. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
11. New treatment for ragweed hayfever: polymerized ragweed. Patterson R Ann Allergy; 1985 Jul; 55(1):77. PubMed ID: 4014791 [No Abstract] [Full Text] [Related]
12. [Comparative study of the effectiveness of 2 methods of specific immunotherapy of pollinoses]. Polsacheva OV; Gushchin IS; Poroshina IuA; Chitaeva VG; Shustova VI Ter Arkh; 1986; 58(4):120-3. PubMed ID: 2424113 [No Abstract] [Full Text] [Related]
14. Possible approaches to turn off the IgE response. Ishizaka K Ann Allergy; 1982 Jun; 48(6):320-4. PubMed ID: 6178322 [No Abstract] [Full Text] [Related]
16. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma. Hesse L; Nawijn MC Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043 [TBL] [Abstract][Full Text] [Related]
17. Clinical and immunologic aspects of allergen-specific immunotherapy in patients with seasonal allergic rhinitis and/or allergic asthma. Rocklin RE J Allergy Clin Immunol; 1983 Oct; 72(4):323-38. PubMed ID: 6194195 [No Abstract] [Full Text] [Related]
18. Comparison of Rinkel injection therapy with standard immunotherapy. Hirsch SR; Kalbfleisch JH; Cohen SH J Allergy Clin Immunol; 1982 Sep; 70(3):183-90. PubMed ID: 7108070 [No Abstract] [Full Text] [Related]
20. Specific IgE and IgG antibody responses in children to timothy pollen components during immunotherapy. Nordvall SL; Renck B; Einarsson R Allergy; 1989 Aug; 44(6):380-4. PubMed ID: 2802111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]